Literature DB >> 15677538

Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.

M M Vleugel1, A E Greijer, A Shvarts, P van der Groep, M van Berkel, Y Aarbodem, H van Tinteren, A L Harris, P J van Diest, E van der Wall.   

Abstract

BACKGROUND: Intratumorous hypoxia triggers a broad cellular response mediated by the transcription factor hypoxia inducible factor 1 (HIF-1). HIF-1alpha concentrations increase during breast carcinogenesis, and are associated with poor prognosis. An earlier study noted two HIF-1alpha overexpression patterns: diffuse scattered throughout the tissue and confined to perinecrotic cells. AIMS: To investigate the prognostic impact of these different HIF-1alpha overexpression patterns in relation to its downstream effectors carbonic anhydrase (CA) IX and glucose transporter 1 (GLUT-1).
METHODS: HIF-1alpha, CA IX, and GLUT-1 expression was studied by immunohistochemistry, including double staining for CA IX and HIF-1alpha. Clinical data included disease free survival, lymph node status, and tumour size.
RESULTS: HIF-1alpha overexpression (44% of cases) had a perinecrotic (13.5%) or diffuse staining pattern (30.5%). CA IX expression was detectable in 12.5% of breast cancers, whereas GLUT-1 expression was seen in 29%, with both showing perinecrotic membrane staining. Perinecrotic HIF-1alpha overexpression was highly associated with CA IX and GLUT-1 overexpression, and double staining for HIF-1alpha and CA IX showed strong expression in the same cells. Diffusely overexpressed HIF-1alpha was not associated with CA IX or GLUT-1 expression. Patients with diffuse HIF-1alpha staining had a significantly better prognosis than patients with perinecrotically overexpressed HIF-1alpha.
CONCLUSIONS: Different regulation pathways of HIF-1alpha overexpression exist in breast cancer: (1) hypoxia induced, perinecrotic HIF-1alpha overexpression with strong expression of hypoxia associated genes (CA IX and GLUT-1), which is associated with a poor prognosis; and (2) diffuse HIF-1alpha overexpression lacking major hypoxia associated downstream effects, resulting in a more favourable prognosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15677538      PMCID: PMC1770566          DOI: 10.1136/jcp.2004.019885

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  35 in total

1.  Hypoxia-inducible expression of tumor-associated carbonic anhydrases.

Authors:  C C Wykoff; N J Beasley; P H Watson; K J Turner; J Pastorek; A Sibtain; G D Wilson; H Turley; K L Talks; P H Maxwell; C W Pugh; P J Ratcliffe; A L Harris
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

2.  Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer.

Authors:  D M Aebersold; P Burri; K T Beer; J Laissue; V Djonov; R H Greiner; G L Semenza
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

Review 3.  HIF-1 and mechanisms of hypoxia sensing.

Authors:  G L Semenza
Journal:  Curr Opin Cell Biol       Date:  2001-04       Impact factor: 8.382

Review 4.  Facilitative glucose transporter expression in human cancer tissue.

Authors:  T A Smith
Journal:  Br J Biomed Sci       Date:  1999       Impact factor: 3.829

5.  Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis.

Authors:  R Bos; H Zhong; C F Hanrahan; E C Mommers; G L Semenza; H M Pinedo; M D Abeloff; J W Simons; P J van Diest; E van der Wall
Journal:  J Natl Cancer Inst       Date:  2001-02-21       Impact factor: 13.506

Review 6.  Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects.

Authors:  M Höckel; P Vaupel
Journal:  J Natl Cancer Inst       Date:  2001-02-21       Impact factor: 13.506

7.  Local imbalance of proangiogenic and antiangiogenic factors: a potential mechanism of focal necrosis and dormancy in tumors.

Authors:  S Ramanujan; G C Koenig; T P Padera; B R Stoll; R K Jain
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

8.  Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia.

Authors:  C Chen; N Pore; A Behrooz; F Ismail-Beigi; A Maity
Journal:  J Biol Chem       Date:  2000-12-18       Impact factor: 5.157

9.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.

Authors:  H Zhong; A M De Marzo; E Laughner; M Lim; D A Hilton; D Zagzag; P Buechler; W B Isaacs; G L Semenza; J W Simons
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

10.  Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment.

Authors:  R Michalides; H van Tinteren; A Balkenende; J B Vermorken; J Benraadt; J Huldij; P van Diest
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

View more
  90 in total

1.  The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.

Authors:  Kuppusamy Balamurugan; Ju-Ming Wang; Hsin-Hwa Tsai; Shikha Sharan; Miriam Anver; Robert Leighty; Esta Sterneck
Journal:  EMBO J       Date:  2010-11-12       Impact factor: 11.598

2.  Noninvasive detection of breast cancer lymph node metastasis using carbonic anhydrases IX and XII targeted imaging probes.

Authors:  Narges K Tafreshi; Marilyn M Bui; Kellsey Bishop; Mark C Lloyd; Steven A Enkemann; Alexis S Lopez; Dominique Abrahams; Bradford W Carter; Josef Vagner; Stephen R Grobmyer; Stephen R Gobmyer; Robert J Gillies; David L Morse
Journal:  Clin Cancer Res       Date:  2011-10-20       Impact factor: 12.531

Review 3.  Molecular responses to hypoxia-inducible factor 1α and beyond.

Authors:  Jason Brocato; Yana Chervona; Max Costa
Journal:  Mol Pharmacol       Date:  2014-02-25       Impact factor: 4.436

4.  Immunohistochemical study of the angiogenetic network of VEGF, HIF1α, VEGFR-2 and endothelial nitric oxide synthase (eNOS) in human breast cancer.

Authors:  Maria Kafousi; Thomas Vrekoussis; Eleftheria Tsentelierou; Kitty Pavlakis; Iordanis Navrozoglou; Vassilios Dousias; Elias Sanidas; Dimitrios Tsiftsis; Vassilios Georgoulias; Efstathios N Stathopoulos
Journal:  Pathol Oncol Res       Date:  2011-06-14       Impact factor: 3.201

5.  Hypoxia induces differential translation of enolase/MBP-1.

Authors:  Kara C Sedoris; Shelia D Thomas; Donald M Miller
Journal:  BMC Cancer       Date:  2010-04-22       Impact factor: 4.430

6.  Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4.

Authors:  Patricia A Cronin; Jiang H Wang; H Paul Redmond
Journal:  BMC Cancer       Date:  2010-05-21       Impact factor: 4.430

7.  Hypoxia-inducible factor-1 as a therapeutic target in endometrial cancer management.

Authors:  Laura M S Seeber; Ronald P Zweemer; René H M Verheijen; Paul J van Diest
Journal:  Obstet Gynecol Int       Date:  2010-02-14

8.  Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.

Authors:  Laura M S Seeber; Nicole Horrée; Petra van der Groep; Elsken van der Wall; René H M Verheijen; Paul J van Diest
Journal:  BMC Cancer       Date:  2010-06-19       Impact factor: 4.430

9.  Expression of BNIP3 in invasive breast cancer: correlations with the hypoxic response and clinicopathological features.

Authors:  Esther A Koop; Theo van Laar; Dick F van Wichen; Roel A de Weger; Elsken van der Wall; Paul J van Diest
Journal:  BMC Cancer       Date:  2009-06-09       Impact factor: 4.430

10.  Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype.

Authors:  K Ameri; R Luong; H Zhang; A A Powell; K D Montgomery; I Espinosa; D M Bouley; A L Harris; S S Jeffrey
Journal:  Br J Cancer       Date:  2010-01-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.